Swedish Orphan Biovitrum AB (publ) ( BIOVF) - Stock Earnings
BIOVF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 27, 2026, midnight | — / — | — | — / — | — |
BIOVF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 201.7 million USD | 847.3 million USD |
| 2026Q1 | 137.7 million USD | 750.4 million USD |
| 2026Q2 | 113.0 million USD | 807.6 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BIOVF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 239.2 million USD | 2.2 billion USD |
| 2024 | 353.2 million USD | 2.4 billion USD |
| 2025 | 51.8 million USD | 3.1 billion USD |
| 2026 Est. | — | — |
BIOVF
Price: $47.35
52 week price:
Earnings Per Share: 0.40 USD
P/E Ratio: 122.57
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 14.9 billion